Bergenbio AS revenue for the last year amounted to 19.64 k USD, the most of which — 34.75 k USD — came from its highest performing source at the moment, Innovative Drugs, the year earlier bringing 39.66 k USD. The greatest contribution to the revenue figure was made by Norway — last year it brought Bergenbio AS 34.75 k USD, and the year before that — 39.66 k USD.